MedTrace Logo

Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System

NCT01494571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2013-03-07

No results posted yet for this study

Summary

The PharmaJet needle-free injection system is a consistent approach to delivering injectates into the dermal layer of the human skin for the purpose of vaccination or medication delivery.

Conditions

  • Functionality and Performance of Device

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Jeffrey Galinkin, MD · Children's Hospital Colorado

Eligibility

Min Age
2 Months
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01494571 on ClinicalTrials.gov